Data / Drug companies / Diclofenac
Diclofenac: 12 companies and 15 products in the FDA NDC directory
Diclofenac is listed in the FDA National Drug Code Directory by 12 companies, with 15 products in commercial distribution. 13 of the products (86.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are solution; gel; patch, and the newest product started marketing on June 7, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 12
- Products
- 15
- Generic (ANDA) products
- 13 (86.7%)
- Application numbers
- 5
- Routes
- Topical, Transdermal, Oral
- Brand names
- Xiclo
- openFDA record search
- api.fda.gov
Companies that list diclofenac
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Advanced Rx of Tennessee, LLC | 2 | tablet, delayed release; solution | Generic drugs (ANDA) | May 19, 2023 |
| Amneal Pharmaceuticals LLC | 2 | solution | Generic drugs (ANDA) | August 23, 2022 |
| Asclemed USA, Inc. | 2 | solution; patch | Generic drugs (ANDA) | June 7, 2025 |
| A-S Medication Solutions | 1 | solution | Generic drugs (ANDA) | September 2, 2016 |
| Amneal Pharmaceuticals NY LLC | 1 | gel | Generic drugs (ANDA) | March 21, 2016 |
| Bryant Ranch Prepack | 1 | solution | Generic drugs (ANDA) | September 2, 2016 |
| Encube Ethicals, Inc. | 1 | solution | Generic drugs (ANDA) | April 14, 2025 |
| Phoenix RX LLC | 1 | solution | Generic drugs (ANDA) | September 2, 2016 |
| Preferred Pharmaceuticals Inc. | 1 | solution | Generic drugs (ANDA) | January 11, 2019 |
| Proficient Rx LP | 1 | solution | Generic drugs (ANDA) | September 2, 2016 |
| Scholls Wellness Company LLC | 1 | gel | Generic drugs (ANDA) | October 30, 2020 |
| Strand Health Group | 1 | patch | Other unapproved drugs | February 7, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Solution | 10 | 66.7% |
| Gel | 2 | 13.3% |
| Patch | 2 | 13.3% |
| Tablet, delayed release | 1 | 6.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 13 | 86.7% |
| Other unapproved drugs | 2 | 13.3% |
Pharmacologic classes
| Class | Products |
|---|---|
| Nonsteroidal Anti-inflammatory Drug | 15 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.